Trial intelligence / Profile preview

Ketamine for Postoperative Nausea and Vomiting in Lumbar Spinal Surgery

NCT01394406Phase 4Completed

Sponsor
Yonsei University
Start
Jan 2010
Primary completion
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ketamine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Yonsei University. Primary endpoint: Incidence of postoperative nausea and vomiting at 48 hours. Started Jan 2010; status: completed.

02

Drugs

ketamine
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT01394406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01394406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call